The Trump administration will allow small employers to use tax-free health reimbursement accounts (HRAs) to provide health coverage to workers; the number of fatal drug overdoses nationwide has fallen for 6 consecutive months; a pilot study with a small sample size of 8 people discovered that microplastics can make their way into the human gut.
The Trump administration will allow small employers to use tax-free health reimbursement accounts (HRAs) to provide health coverage to workers, the Associated Press reported. Under the plan, expected to be formally announced Tuesday, employees could buy their own individual health insurance policies. Health policy critics have said the approach will undermine traditional job-based coverage, and the Obama administration had discouraged the practice. HRAs join other health insurance changes, including association health plans and short-term policies.
The number of fatal drug overdoses nationwide has fallen for 6 consecutive months, reversing a sharp rise during the past few years, but public health experts warned against drawing firm conclusions based on a small timeframe, STAT News reported. In in the 12-month period ending in March 2018, the CDC reported a decline of 2.8% in the number of overdose deaths, to an estimated 71,073 people, compared with the 12 months ending in September 2017.
A pilot study with a small sample size of 8 people discovered that microplastics can make their way into the human gut, The New York Times reported. In a European study, researchers examined stool samples from volunteers in 8 countries and were surprised when every single sample tested positive for the presence of a variety of microplastics. Microplastics, about the size of a grain of rice, have become a major concern for environmental researchers over the past decade as plastic bags and bottles make their way into the ocean. The most common plastics detected were polypropylene and polyethylene terephthalate—both major components of plastic bottles and caps. The health effects are unknown and more research is needed.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More